Synthomer (SYNT) Q3 2026 TU earnings summary

Executive summary

• Q3 2026 performance in line with previously upgraded FY expectations, with continuing operations delivering higher volume, revenue and EBITDA YoY.

• Strategic initiatives, innovation and cost efficiency supported momentum; FY 2026 outlook reaffirmed, with positive momentum expected to continue in 2027.

Financial highlights

• Continuing operations recorded Q3 growth in volume, revenue and EBITDA vs Q3 2025; the update cited a strong H1 EBITDA outturn.

• Year-to-date margins progressed in all three divisions, supported by cost management and pass-through of higher raw material costs.

Outlook and guidance

• FY 2026 outlook reaffirmed, based on H1 EBITDA and expected ongoing strategic growth and cost-efficiency progress.

• Positive free cash flow expected for FY 2026 before movements in non-recourse receivables financing.

• Strategic initiatives are expected to sustain positive momentum in 2027; execution aims to drive earnings growth and improved free cash flow.